Timetable 2024

09:00-09:15	Official opening
09:15-09:40	Tobias Bald University of Bonn, Germany NK cell plasticity in cancer
09:40-10:05	Kazuyo Moro RIKEN/Osaka University, Japan The Impact of Appendectomy on Ulcerative Colitis
10:05-10:30	Jakub Gołąb Medical University of Warsaw, Poland The roles of arginases in mitigation of antitumor immunity
10:30-10:55	Aurélie Poli Luxembourg Institute of Health, Luxembourg AllergoOncology: Lessons Learned from the Allergy-Glioblastoma Connection
10:55-11:20	Alexandros Drainas BioMed X, Germany The quest to eliminate ecDNA in cancer cells
11:20-11:40	Break
11:40-12:05	Andrew Shepherd University of Texas MD Anderson Cancer Center, USA Pain neurons control cancer immunosurveillance
12:05-12:30	Hrvoje Miletic University of Bergen, Norway Cell communication and mitochondria transfer in brain tumors
12:30-12:55	Anne-Marie Heegaard University of Copenhagen, Denmark Pain in Multiple Myeloma – interaction of the cancer microenvironment with the sensory nervous system
12:55-13:20	Sébastien Talbot (online) Queen’s University, ON, Canada Peripheral Nerve Injury Induced by Colorectal Cancer: Mechanisms and Implications for Chemotherapy-Induced Peripheral Neuropathy
13:20-13:30	Sponsor presentation: Altium
13:30-14:30	Lunch
14:30-14:55	Claudio Ballabio The Francis Crick Institute, United Kingdom Tumour intrinsic electrical activity drives small-cell lung cancer progression
14:55-15:20	Yuan Pan (online) University of Texas MD Anderson Cancer Center, USA The Cancer Neuroscience of Neurofibromatosis type 1 (NF1)
15:20-15:45	Dominika Nowis Medical University of Warsaw, Poland The use of mRNA-based immunotherapies in experimental oncology
15:45-16:10	Helena Florindo University of Lisbon, Portugal Unveiling Solid Tumor Microenvironment for revolutionary nano-immunotherapies
16:10-17:00	Break (Industry Contact Point introduction to Matchmaking + Matchmaking Session)
17:00-18:00	Opening Keynote Melody Swartz University of Chicago, USA The yin and yang of tumor-associated lymphatics in metastasis and anti-tumor immunity

09:00-10:30	EIT Health – Morning Health Talks
	Monika Ślęzak (panel moderator) Industry Contact Point Medical Technologies and Health, Łukasiewicz – PORT Marek Kozłowski Venture Capital – Life Science & Healthcare NRW.Venture Michał Malewicz Life Science & Biotechnology Center, Łukasiewicz – PORT Michał Zawisza Woyczyński Saving Kids with Cancer Foundation Marek Sipowicz WPD Pharmaceuticals Inc. Monika Litwin Lower Silesian Center of Oncology, Pulmonology and Hematology Magdalena Sobocińska NU-MED Specialist Oncology Hospital in Tomaszów Mazowiecki Magdalena Ciążyńska NU-MED Specialist Oncology Hospital in Tomaszów Mazowiecki
10:30-10:40	Break
10:40-11:05	Carlos-Filipe Pereira Lund University, Sweden Empowering Cancer Immunotherapy with Cellular Reprogramming
11:05-11:30	Rafael Blanco Domínguez University of Lisbon, Portugal Delta One T cells in Cancer Immunotherapy
11:30-11:55	Helen Kakkassery King’s College London, United Kingdom Investigating the immune surveillance mechanisms in atypical responders of stage IV breast cancers following standard of care chemo – and targeted therapies
11:55-12:55	Conference brunch
12:55-13:20	Thanussuyah Alaguthurai King’s College London, United Kingdom Translational Research Programme- Facilitating oncology research at Guy’s
13:20-13:45	Marco Gustav Dresden University of Technology, Germany Deep Learning-based Biomarkers for Precision Oncology
13:45-13:55	Break
13:55-14:20	Christoph Klose Charité – Berlin University Medicine, Germany Neuro-immune interactions at barrier surfaces
14:20-14:45	Bożena Kamińska Nencki Institute of Experimental Biology of the Polish Academy of Sciences, Poland Taming tumor microenvironment with siRNAs and innovative nanocarriers in malignant gliomas
14:45-15:55	Company session Molecure, Celon Pharma, Ryvu Therapeutics, International Centre for Cancer Vaccine Science (University of Gdańsk), Ardigen, Cellis, Cancer Center
15:55-16:00	Official closure